15-F2t-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 4 58-4, 2005, Pages

  Xia, Zhengyuan ^a,c   Kuo, Kuo Hsing ^a,b   Godin, David V ^a   Walker, Michael J ^a   Tao, Michelle C Y ^a   Ansley, David M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Endothelin 1; Ischemia reperfusion injury; SQ 29548

Indexed keywords

15 F2T ISOPROSTANE; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CREATINE KINASE MB; ENDOTHELIN 1; ISOPROSTANE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE EXACERBATION; ENZYME IMMUNOASSAY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; CREATINE KINASE; CREATINE KINASE, MB FORM; DINOPROST; ENDOTHELIN-1; HEART; ISOENZYMES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTOR AGENTS;

EID: 25444448730     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00042.2005     Document Type: Article

References (38)

1. t-isoprostane concentration and early postoperative cardiac depression following warm heart surgery. J Thorac Cardiovasc Surg 126: 1222-1223, 2003.
2. Bond BR, Dorman BH, Clair MJ, Walker CA, Pinosky ML, Reeves ST, Walton S, Kratz JM, Zellner JL, Crumbley AJ III, Multani MM, and Spinale FG. Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg 122: 358-364, 2001.
3. Brunner F. Cardiac tissue endothelin-1 levels under basal, stimulated, and ischemic conditions. J Cardiovasc Pharmacol 26, Suppl 3: S44-S46, 1995.
4. Brunner F and Opie LH. Role of endothelin-A receptors in ischemic contracture and reperfusion injury. Circulation 97: 391-398, 1998.
5. Bugge E and Ytrehus K. Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart. Cardiovasc Res 32: 920-929, 1996.
6. 2 mimetic in rat heart smooth muscle cells. Biochim Biophys Acta 1313: 1-5, 1996.
7. Dorman BH, Bond BR, Clair MJ, Walker CA, Pinosky ML, Reeves ST, Kratz JM, Zellner JL, Crumbley AJ III, Multani MM, and Spinale FG. Temporal synthesis and release of endothelin within the systemic and myocardial circulation during and after cardiopulmonary bypass: relation to postoperative recovery. J Cardiothorac Vasc Anesth 14: 540-545, 2000.
8. Downey JM. Measuring infarct size by the tetrazolium method [Online]. http:/www.usouthal.edu/ishr/help/ttc [15 July 2003].
9. Gan XT, Chakrabarti S, and Karmazyn M. Increased endothelin-1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation. Can J Physiol Pharmacol 81: 105-113, 2003.
10. A receptor and the mitochondrial KATP channel in the rat in vivo. Br J Pharmacol 144: 331-337, 2005.
11. + exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts. Circ Res 75: 369-378, 1994.
12. Kloner RA, Przyklenk K, and Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 80: 1115-1127, 1989.
13. 2α. Br J Pharmacol 119: 1276-1280, 1996.
14. 2α, in the hypoxic rat heart. Br J Pharmacol 126: 1171-1174, 1999.
15. Li XY, McCay PB, Zughaib M, Jeroudi MO, Triana JF, and Bolli R. Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest 92: 1025-1041, 1993.
16. Liu JJ, Casley DJ, and Nayler WG. Ischaemia causes externalization of endothelin-1 binding sites in rat cardiac membranes. Biochem Biophys Res Commun 164: 1220-1225, 1989.
17. Meerson FZ, Kagan VE, Kozlov YuP, Belkina LM, and Arkhipenko Yu V. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 77: 465-485, 1982.
18. Mehlhorn U, Krahwinkel A, Geissler HJ, LaRosee K, Fischer UM, Klass O, Suedkamp M, Hekmat K, Tossios P, and Bloch W. Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia. J Thorac Cardiovasc Surg 125: 178-183, 2003.
19. 2α increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol 18: 1248-1256, 1998.
20. 2) in isolated guinea pig hearts. J Cardiovasc Pharmacol 29: 789-794, 1997.
21. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383-9387, 1990.
22. Morrow JD, Minton TA, Mukundan CR, Campbell MD, Zackert WE, Daniel VC, Badr KF, Blair IA, and Roberts LJ II. Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem 269: 4317-4326, 1994.
23. Neubauer S, Zimmermann S, Hirsch A, Pulzer F, Tian R, Bauer W, Bauer B, and Ertl G. Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury. J Mol Cell Cardiol 23: 1397-1409, 1991.
24. Ogletree ML, Harris DN, Greenberg R, Haslanger MF, and Nakane M. Pharmacological actions of SQ 29548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 234: 435-441, 1985.
25. Pearl JM, Nelson DP, Wagner CJ, Lombardi JP, and Duffy JY. Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation. Ann Thorac Surg 72: 565-570, 2001.
26. Przyklenk K and Kloner RA. Is "stunned myocardium" a protective mechanism? Effect of acute recruitment and acute β-blockade on recovery of contractile function and high-energy phosphate stores at 1 day post-reperfusion. Am Heart J 118: 480-489, 1989.
27. Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT, and Gallagher KP. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function. Circulation 95: 1918-1929, 1997.
28. Taber DF, Morrow JD, and Roberts LJ II. A nomenclature system for the isoprostanes. Prostaglandins 53: 63-67, 1997.
29. 2 receptors. J Clin Invest 90: 136-141, 1992.
30. Ulus AT, Aksoyek A, Ozkan M, Katircioglu SF, and Basu S. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic Biol Med 34: 911-917, 2003.
31. Verma S, Maitland A, Weisel RD, Fedak PW, Li SH, Mickle DA, Li RK, Ko L, and Rao V. Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: reversal by means of endothelin antagonism. J Thorac Cardiovasc Surg 123: 1114-1119, 2002.
32. Wang Y and Wang DH. Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP. Am J Physiol Heart Circ Physiol 287: H1868-H1874, 2004.
33. 2t-isoprostane formation and tissue antioxidant capacity. Cardiovasc Res 59: 113-121, 2003.
34. 2t-isoprostane formation. Can J Physiol Pharmacol 81: 14-21, 2003.
35. 2 after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg 126: 1404-1410, 2003.
36. Xia Z, Kuo KH, McNeill JH, and Ansley DM. Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration. Can J Physiol Pharmacol 83: 259-266, 2005.
37. 2 in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors. Circulation 104: 2210-2215, 2001.
38. Zaugg CE, Zhu P, Simper D, Luscher TF, Allegrini PR, and Buser PT. Differential effects of endothelin-1 on normal and postischemic reperfused myocardium. J Cardiovasc Pharmacol 22, Suppl 8: S367-S370, 1993.